It seems as if the yanks are in control now. I don't see any way that Fuji can acquire us. The most they can do at this stage is exercise their GVHD option if the Cohort B results are good. I'm sure a GVHD treatment wasn't their only intention when they 1st set out on getting involved with Cynata...
We have Fidelity with a blocking stake (likely involved with Celularity), many indicators that we will likely be more involved in the US (the FDA wanted Cynata to conduct the GVHD trial in the US + Orphan status etc).
I feel as if we are either going to go it alone (with backers / partners) or get bought out by someone big out of the US.
Thoughts?
Fuji dropped the ball
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $52.99M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.5¢ | 27.5¢ | $29.94K | 106.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 10159 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |